Nature Biotechnology, Published online: 12 November 2026; doi:10.1038/s41587-026-03378-9 An analysis of Investigational New Drug (IND) submissions to the US Food and Drug Administration (FDA) from 1995 to 2025 reveals a rapid growth in adeno-associated virus (AAV) development over three decades and highlights common reasons for regulatory holds that should be considered for successful product development.
Sojin Bing, Takele Argaw, Megha Kaushal, Ronit Mazor. A comprehensive analysis of CBER experience with AAV gene therapy IND submissions. // Nature Biotechnology. – 2026. – DOI: 10.1038/s41587-026-03378-9. – URL: https://www.nature.com/articles/s41587-026-03378-9
Sojin Bing, Takele Argaw, Megha Kaushal, & Ronit Mazor (2026). A comprehensive analysis of CBER experience with AAV gene therapy IND submissions. Nature Biotechnology. https://doi.org/10.1038/s41587-026-03378-9
Sojin Bing, et al. “A comprehensive analysis of CBER experience with AAV gene therapy IND submissions.” Nature Biotechnology, 2026. doi:10.1038/s41587-026-03378-9.
@article{Bing2026,
title = {A comprehensive analysis of CBER experience with AAV gene therapy IND submissions},
author = {Bing, Sojin and Argaw, Takele and Kaushal, Megha and Mazor, Ronit},
journal = {Nature Biotechnology},
year = {2026},
doi = {10.1038/s41587-026-03378-9},
url = {https://www.nature.com/articles/s41587-026-03378-9}
}
The growing recognition of base editing as a precise genome-engineering strategy for single‑nucleotide conversions without double‑strand breaks has increased interest in its application to animal agriculture, where many economically...
Sensorineural hearing loss (SNHL) is a prevalent auditory disorder, with noise exposure being its primary etiological factor; however, its molecular mechanisms and therapeutic targets remain poorly understood. This study integrated...
Nature Biotechnology, Published online: 16 November 2026; doi:10.1038/s41587-026-03344-5 Adeno-associated virus vectors targeted to CD7 enable T and NK cell engineering in vivo.